TAIHUSNOW CO.,LTD.
838262
Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
CN Stock MarketDetailed Quotes
000702 Hunan Zhenghong Science And Technology Develop
- 8.31
- -0.52-5.89%
Not Open Dec 16 15:00 CST
2.88BMarket Cap-26.38P/E (TTM)
8.80High8.24Low187.82KlotVolume8.80Open8.83Pre Close157.99MTurnover7.04%Turnover RatioLossP/E (Static)346.62MShares10.5552wk High7.04P/B2.22BFloat Cap2.9452wk Low9.71Limit Up266.63MShs Float22.79Historical High7.95Limit Down6.34%Amplitude2.35Historical Low--Dividend TTM8.41Avg Price107.88KlotAsk--Div YieldTTM100Lot Size78.25KlotBid
Hunan Zhenghong Science And Technology Develop Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -13.39%194.8M | 24.37%204.41M | 36.48%170.97M | 223.38%248.54M | 126.99%224.93M | 56.79%164.36M | 107.48%125.27M | -24.84%76.86M | -7.68%99.09M | -19.10%104.83M |
| Transactional financial assets | ---- | -20.95%1.55M | ---- | ---- | --1.5M | --1.96M | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 43.40%52.01M | 131.23%50.25M | 408.49%41.96M | 34.59%21.19M | 317.79%36.27M | 4,068.54%21.73M | 183.19%8.25M | 317.76%15.74M | 43.56%8.68M | -90.43%521.29K |
| -Accounts receivable | 43.40%52.01M | 131.23%50.25M | 408.49%41.96M | 34.59%21.19M | 317.79%36.27M | 4,068.54%21.73M | 183.19%8.25M | 317.76%15.74M | 43.56%8.68M | -90.43%521.29K |
| Other receivables (including interest and dividends) | -77.02%1.65M | -74.55%1.68M | -77.45%1.73M | -73.22%1.55M | 20.65%7.18M | 23.50%6.61M | 46.35%7.66M | 24.74%5.8M | -40.74%5.95M | 31.73%5.35M |
| -Other receivable | ---- | -74.55%1.68M | ---- | ---- | ---- | 23.50%6.61M | ---- | 24.74%5.8M | ---- | 31.73%5.35M |
| Advance payment | -36.04%15.48M | 0.63%21.38M | 13.57%18.05M | -19.07%13.71M | 38.05%24.2M | 197.86%21.25M | 42.13%15.89M | 121.64%16.94M | -11.82%17.53M | -68.04%7.13M |
| Inventories | 27.44%138.56M | -36.76%82.34M | -51.24%83.16M | -68.76%68.76M | -47.36%108.73M | -38.18%130.2M | -24.26%170.56M | -3.38%220.1M | -13.10%206.54M | -39.47%210.6M |
| Other current assets | 76.26%3.18M | 171.66%1.05M | -50.33%626.69K | -45.22%414.07K | 255.96%1.8M | -66.30%385.24K | -44.55%1.26M | -79.29%755.93K | -79.23%506.7K | -56.02%1.14M |
| Total current assets | 0.26%405.68M | 4.67%362.65M | -3.77%316.49M | 5.35%354.17M | 19.60%404.62M | 5.13%346.49M | 7.07%328.89M | -3.88%336.19M | -13.63%338.3M | -36.83%329.58M |
| Non Current assets | ||||||||||
| Other equity investment | 7.82%29.52M | 2.03%24.69M | 0.97%26.04M | 2.43%24.18M | 12.98%27.38M | -2.53%24.2M | 3.41%25.79M | -18.62%23.61M | -19.93%24.24M | -28.31%24.83M |
| Other non-current financial assets | ---- | --195.71K | --532.71K | --995.39K | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | 74.97%114.35M | 74.48%116.65M | 73.75%118.98M | 72.96%121.25M | -8.59%65.35M | -8.26%66.86M | -7.79%68.48M | -7.34%70.1M | -1.57%71.49M | -1.46%72.88M |
| Long-term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.35%2.97M | -15.69%3.89M |
| Long term receivable account | --965.78K | --2.67M | --3.08M | --3.07M | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | -25.58%173.45M | ---- | ---- | ---- | -8.17%233.08M | ---- | -7.67%243.01M | ---- | -4.32%253.81M |
| Constru in process | ---- | --238.3K | ---- | ---- | ---- | ---- | ---- | -85.54%36K | ---- | -99.23%32K |
| Productive biological assets | -11.63%12.25M | -29.93%12.66M | -56.69%11.3M | -85.04%5.3M | -62.49%13.86M | -61.48%18.07M | -38.39%26.08M | -23.57%35.45M | -46.66%36.96M | -54.99%46.91M |
| Intangible assets | -71.25%7.11M | -72.33%6.98M | -69.55%7.82M | -68.67%8.21M | -5.81%24.75M | -0.97%25.24M | -0.75%25.69M | -3.03%26.19M | -4.38%26.28M | -8.29%25.49M |
| Usufruct assets | -69.36%13.09M | -72.35%14.78M | -71.61%16.29M | -72.14%17.29M | -45.77%42.74M | -42.69%53.43M | -36.94%57.37M | -41.07%62.05M | -21.92%78.8M | 9.52%93.23M |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.01M |
| Total non current assets | -13.78%346.6M | -16.29%352.33M | -17.56%364.08M | -20.95%363.99M | -17.73%401.99M | -19.38%420.88M | -15.22%441.65M | -16.48%460.45M | -15.02%488.6M | -12.95%522.07M |
| Total assets | -6.74%752.28M | -6.83%714.98M | -11.68%680.57M | -9.85%718.15M | -2.45%806.61M | -9.90%767.37M | -6.95%770.54M | -11.59%796.64M | -14.45%826.9M | -24.06%851.65M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 9.91%296.75M | -35.64%276.75M | -38.31%246.75M | -38.37%265.33M | -37.93%270M | -0.86%430M | 7.67%400M | 11.42%430.55M | 6.60%435M | 11.22%433.74M |
| Transactional financial liabilities | ---- | --2.97M | ---- | 16.81%1.75M | ---- | ---- | --411.44K | --1.5M | ---- | ---- |
| Notes payable and accounts payable | -9.49%57.84M | -46.70%36.84M | -40.84%37.38M | -60.65%37.14M | -31.19%63.9M | -21.49%69.11M | -25.11%63.19M | 16.05%94.39M | -16.03%92.87M | -0.27%88.04M |
| -Accounts payable | -9.49%57.84M | -46.70%36.84M | -40.84%37.38M | -60.65%37.14M | -31.19%63.9M | -21.49%69.11M | -25.11%63.19M | 16.05%94.39M | 6.02%92.87M | 3.24%88.04M |
| Contract liabilities | 116.86%31.18M | 62.80%21.55M | 20.38%15.4M | 74.24%9.58M | 12.97%14.38M | -33.73%13.24M | -52.63%12.79M | -46.71%5.5M | 25.81%12.73M | -13.79%19.98M |
| Advance receipts | 3.29%557.28K | 55.28%860.95K | 42.58%757.45K | 156.08%1.25M | 35.59%539.53K | 139.77%554.46K | 39.37%531.24K | 2.46%488.21K | 20.31%397.91K | -3.48%231.24K |
| Salaries payable | 8.70%9.61M | -8.87%9.81M | -30.83%9.21M | 51.99%12.57M | -3.80%8.84M | 0.85%10.77M | 16.25%13.32M | -25.33%8.27M | -26.02%9.19M | -17.64%10.68M |
| Taxs payable | -39.83%2.35M | -39.55%1.83M | -35.17%1.6M | -41.96%1.91M | 1.80%3.91M | -17.87%3.04M | -16.75%2.46M | -38.70%3.29M | 78.38%3.84M | 63.10%3.7M |
| Other payable (including interest and dividends) | -38.89%17.66M | -87.25%18.08M | -86.13%20.1M | -58.52%29.53M | 4.56%28.9M | 431.89%141.8M | 425.82%144.94M | 169.95%71.18M | -35.24%27.64M | -37.77%26.66M |
| -Other payable | ---- | -87.25%18.08M | ---- | ---- | ---- | 431.89%141.8M | ---- | 169.95%71.18M | ---- | -37.77%26.66M |
| Non current liabilities due within one year | -73.66%3.15M | -50.04%7.88M | -51.03%8.3M | -61.44%7.59M | --11.95M | --15.77M | --16.94M | --19.68M | ---- | ---- |
| Other current liabilities | ---- | ---- | ---- | --157.6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current liabilities | 4.14%419.1M | -44.97%376.57M | -48.05%340.07M | -42.22%366.81M | -30.82%402.42M | 17.37%684.28M | 24.62%654.59M | 21.77%634.85M | -0.80%581.67M | 4.16%583.03M |
| Current liabilities | ||||||||||
| Long term deferred income | -11.45%8.42M | -11.13%8.7M | -10.84%8.97M | -10.55%9.24M | -10.28%9.51M | -10.76%9.79M | -10.54%10.06M | -9.54%10.33M | -6.09%10.6M | -5.16%10.96M |
| Lease liabilities | -71.76%7.01M | -72.15%8.16M | -72.36%8.16M | -67.43%11.14M | -64.04%24.81M | -63.64%29.28M | -62.69%29.51M | -61.97%34.21M | -13.35%68.99M | 13.56%80.54M |
| Total non current liabilities | -55.05%15.43M | -56.87%16.85M | -56.73%17.12M | -54.23%20.38M | -56.88%34.32M | -57.31%39.07M | -56.20%39.57M | -56.07%44.54M | -12.45%79.59M | 10.94%91.5M |
| Total liabilities | -0.51%434.53M | -45.61%393.42M | -48.54%357.19M | -43.01%387.19M | -33.95%436.74M | 7.24%723.35M | 12.76%694.16M | 9.10%679.38M | -2.36%661.26M | 5.03%674.53M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%346.62M | 30.00%346.62M | 30.00%346.62M | 30.00%346.62M | 30.00%346.62M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M | 0.00%266.63M |
| Capital reserve funds | 0.00%436.58M | 136.37%436.58M | 136.37%436.58M | 136.37%436.58M | 136.37%436.58M | 0.00%184.7M | 0.00%184.7M | -0.61%184.7M | 1.81%184.7M | 1.61%184.7M |
| Surplus reserve funds | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 0.00%29.99M | 1.32%29.99M | 1.32%29.99M |
| Retained profit | -31.20%-430.97M | -29.33%-419.95M | -36.96%-417.3M | -48.34%-408.73M | -36.50%-328.49M | -39.71%-324.71M | -49.16%-304.7M | -72.70%-275.53M | -54.54%-240.65M | -694.81%-232.42M |
| Other composite income | 3.42%26.94M | -3.31%22.11M | -4.08%23.46M | 3.71%23.1M | 13.73%26.05M | -2.68%22.87M | 3.61%24.46M | -19.52%22.27M | -20.84%22.9M | -29.44%23.5M |
| Shareholders equity without minority interests | -19.89%409.16M | 131.42%415.35M | 108.55%419.36M | 87.47%427.56M | 93.78%510.76M | -34.11%179.48M | -33.12%201.09M | -34.95%228.07M | -24.88%263.57M | -43.49%272.4M |
| Minority interests | 35.12%-91.41M | 30.76%-93.79M | 23.04%-95.97M | 12.83%-96.6M | -43.87%-140.89M | -42.18%-135.45M | -41.44%-124.71M | -53.42%-110.82M | -59.16%-97.93M | -3,274.53%-95.27M |
| Total shareholder equity | -14.09%317.75M | 630.42%321.56M | 323.39%323.38M | 182.26%330.96M | 123.29%369.86M | -75.14%44.02M | -64.06%76.38M | -57.88%117.25M | -42.75%165.65M | -63.04%177.12M |
| Total liabilityies and equity | -6.74%752.28M | -6.83%714.98M | -11.68%680.57M | -9.85%718.15M | -2.45%806.61M | -9.90%767.37M | -6.95%770.54M | -11.59%796.64M | -14.45%826.9M | -24.06%851.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
